How have RVX shares performed in 2024?

Resverlogix's stock was trading at C$0.07 at the start of the year. Since then, RVX stock has decreased by 21.4% and is now trading at C$0.06. View the best growth stocks for 2024 here .

When is Resverlogix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our RVX earnings forecast .

What other stocks do shareholders of Resverlogix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Resverlogix investors own include ProMetic Life Sciences (PLI) , Aptose Biosciences (APTO) , Oncolytics Biotech (ONC) , Radient Technologies (RTI) , VentriPoint Diagnostics (VPT) , Endocyte (ECYT) , Allena Pharmaceuticals (ALNA) , Catalyst Pharmaceuticals (CPRX) and Royalty Pharma (RPRX) .

How do I buy shares of Resverlogix?

Shares of RVX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:RVX

Resverlogix (RVX) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Free RVX Stock Alerts

C$0.06

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: C$0.05
▼
C$0.06
50-Day Range: C$0.06
▼
C$0.07
52-Week Range: C$0.05
▼
C$0.17

Volume: 2,800 shs
Average Volume: 37,624 shs
Market Capitalization: C$14.97 million

P/E Ratio: N/A
Dividend Yield: 7.02%
Price Target: N/A

Stock Analysis Chart Competitors Earnings Headlines Insider Trades

Get Resverlogix alerts:

Ad Crypto Swap Profits

He Is Giving Away Bitcoin

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About Resverlogix Stock (TSE:RVX)

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada; and developing cardiovascular and pulmonary arterial hypertension indications. The company was founded in 2001 and is headquartered in Calgary, Canada.

RVX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RVX Stock News Headlines

February 21, 2024 | finance.yahoo.com

Resverlogix Announces Change to Its Board of Directors

January 11, 2024 | finance.yahoo.com

Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits

April 20, 2024 | Paradigm Press (Ad)

Biden replacement revealed?

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

January 4, 2024 | theglobeandmail.com

Closing Bell: Resverlogix Corp flat on Tuesday (RVX)

December 19, 2023 | investing.com

Resverlogix Corp. (RVX) Earnings Dates & Reports

November 18, 2023 | morningstar.com

Resverlogix Corp RVXCF

November 1, 2023 | morningstar.com

Resverlogix Corp RVX

October 18, 2023 | theglobeandmail.com

Resverlogix: Top 10 Undervalued Healthcare Sector Stocks on TSX (RVX)

April 20, 2024 | Paradigm Press (Ad)

Biden replacement revealed?

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

October 4, 2023 | finanznachrichten.de

Resverlogix Corp.: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy

October 4, 2023 | finance.yahoo.com

Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy

September 26, 2023 | finance.yahoo.com

Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsight

August 29, 2023 | finance.yahoo.com

Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes

August 24, 2023 | theglobeandmail.com

Closing Bell: Resverlogix Corp up on Wednesday (RVX)

August 14, 2023 | theglobeandmail.com

Closing Bell: Resverlogix Corp flat on Monday (RVX)

July 12, 2023 | theglobeandmail.com

Closing Bell: Resverlogix Corp Warrants down on Wednesday (RVX-WT-A)

June 29, 2023 | finance.yahoo.com

Resverlogix Announces Warrant Repricing and One-Year Extension

June 20, 2023 | finanznachrichten.de

Resverlogix Corp.: Resverlogix Announces Voting Results from the 2023 Meeting of Shareholders

June 20, 2023 | finance.yahoo.com

Resverlogix Announces Voting Results from the 2023 Meeting of Shareholders

June 12, 2023 | finance.yahoo.com

Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

June 7, 2023 | finance.yahoo.com

Canadian Investment Regulatory Organization Trading Halt - RVX.WT.A

June 6, 2023 | theglobeandmail.com

Closing Bell: Resverlogix Corp Warrants down on Friday (RVX-WT-A)

May 25, 2023 | theglobeandmail.com

Closing Bell: Resverlogix Corp Warrants down on Tuesday (RVX-WT-A)

May 18, 2023 | finance.yahoo.com

CBOE RUSSELL 2000 VOLATILITY IN (^RVX)

May 2, 2023 | theglobeandmail.com

Closing Bell: Resverlogix Corp down on Monday (RVX)

April 29, 2023 | theglobeandmail.com

Closing Bell: Resverlogix Corp flat on Friday (RVX)

April 28, 2023 | theglobeandmail.com

Closing Bell: Resverlogix Corp Warrants flat on Thursday (RVX-WT-A)

See More Headlines

Receive RVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Resverlogix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/09/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: TSE:RVX
CUSIP: N/A
CIK: N/A
Web: www.resverlogix.com
Phone: +1-403-2549252
Fax: N/A
Employees: 19
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.05)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-12,820,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -37.10%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.11
Quick Ratio: 0.04

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.00 per share
Price / Cash Flow: 132.50
Book Value: C($0.26) per share
Price / Book: -0.21

Miscellaneous

Outstanding Shares: 272,170,000
Free Float: N/A
Market Cap: C$14.97 million
Optionable: Not Optionable
Beta: 0.78

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Donald J. McCaffrey
Co-Founder, Chairman, President, CEO & Secretary
Mr. Aaron Bradley Cann C.A.
CPA, CBV, Chief Financial Officer
Dr. Ewelina Kulikowski Ph.D.
Chief Scientific Officer
Dr. Michael Sweeney M.D. (Age 63)
Senior Vice President of Clinical Development
Comp: $511.56k
Sarah Zapotichny
Director of Investor Relations & Corporate Communications

Key Competitors

View All Competitors

RVX Stock Analysis - Frequently Asked Questions

How have RVX shares performed in 2024?: Resverlogix's stock was trading at C$0.07 at the start of the year. Since then, RVX stock has decreased by 21.4% and is now trading at C$0.06.
View the best growth stocks for 2024 here.
When is Resverlogix's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our RVX earnings forecast.
What other stocks do shareholders of Resverlogix own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Resverlogix investors own include ProMetic Life Sciences (PLI), Aptose Biosciences (APTO), Oncolytics Biotech (ONC), Radient Technologies (RTI), VentriPoint Diagnostics (VPT), Endocyte (ECYT), Allena Pharmaceuticals (ALNA), Catalyst Pharmaceuticals (CPRX) and Royalty Pharma (RPRX).
How do I buy shares of Resverlogix?: Shares of RVX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:RVX) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial